1. CLOLAR® package insert (2008) Genzyme corporation. http://www.clolar.com/docs/Clolar_Full_PI.pdf . Accessed June 2010
2. Lotfi K, Mansson E, Spasokoukotskaja T et al (1999) Biochemical pharmacology and resistance to 2-chloro-2’-arabino-fluoro-2’-deoxyadenosine, a novel analogue of cladribine in human leukemic cells. Clin Cancer Res 5:2438–2444
3. Parker WB, Shaddix SC, Chang CH et al (1991) Effects of 2-chloro-9-(2-deoxy-2-fluoro-betaD-arabinofuranosyl) adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5¢-triphosphate. Cancer Res 51:2386–2394
4. Genini D, Adachi S, Chao Q et al (2000) Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria. Blood 96:3537–3543
5. Xie C, Plunkett W (1995) Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)-adenine in human lymphoblastoid cells. Cancer Res 55:2847–2852